Condition: Chronic Coronary Syndrome · Sponsor: Shandong First Medical University
This study is a prospective, multicentre, randomized, open-label, blinded-endpoint clinical trial to evaluate the efficacy and safety of Yangxinshi tablets in the treatment of patients with chronic coronary syndrome (CCS).
This description comes directly from the study's public registry record.
Yuan Haitao · 0531-68776356 · doctoryuanht@126.com
Always discuss trial participation with your own doctor first.
| Shapingba District People's Hospital of Chongqing | Chongqing, Chongqing Municipality, China | Not Yet Recruiting |
| Zhengzhou Seventh People's Hospital | Zhengzhou, Henan, China | Not Yet Recruiting |
| Binzhou Medical University Hospital | Binzhou, Shandong, China | Not Yet Recruiting |
| Binzhou People's Hospital | Binzhou, Shandong, China | Not Yet Recruiting |
| Dezhou Municiple Hospital | Dezhou, Shandong, China | Not Yet Recruiting |
| Pingyuan County first People's Hospital | Dezhou, Shandong, China | Not Yet Recruiting |
| Feicheng People's Hospital | Feicheng, Shandong, China | Recruiting |
| Shandong Health Group Feicheng Hospital | Feicheng, Shandong, China | Recruiting |
| Affiliated Hospital of Shandong University of Traditional Chinese Medicine | Jinan, Shandong, China | Recruiting |
| Jinan Central Hospital | Jinan, Shandong, China | Not Yet Recruiting |
| Jinan Zhangqiu District People's Hospital | Jinan, Shandong, China | Not Yet Recruiting |
| Shandong Provincial Hospital Affiliated to Shandong First Medical University | Jinan, Shandong, China | Recruiting |
+ 20 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06171061